Brigatinib is a treatment that focuses on certain parts of cancer cells, especially in ALK-positive metastatic non-small cell lung cancer. It works by blocking a specific signal in ALK cells. You can get the drug in three strengths: 30 mg, 90 mg, and 180 mg pills with a special coating.
The recommended dosing regimen starts with a 90 mg once daily dose for the first 7 days, followed by an increased dosage to 180 mg daily. Each bottle holds 30 pills.
Reviews
There are no reviews yet.